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Abstract:
Vascular endothelial cells stimulation is associated with the activation of 
different signalling pathways and transcription factors. Acute shear 
stress is known to induce different pro-inflammatory mediators such as 
IL-8. Nrf2 is activated by prolonged high shear stress promoting an 
antiinflammatory and athero-protective environment. However, little is 
known about the impact of acute shear stress on Nrf2 and Keap1 
function and its role in IL-8 regulation. We aimed to examine Nrf2-Keap1 
complex activation in-vitro and its role in regulating IL-8 transcripts 
under acute arterial shear stress (12dyn/cm2) in venous endothelial cells 
(ECs). We note that  acute high shear stress caused a significant 
upregulation of Nrf2 target genes, HO-1 and GCLM and an increased IL-8 
upregulation at 90 and 120 min. Mechanistically, acute high shear did 
not affect Nrf2 nuclear translocation but resulted in reduced nuclear 
Keap1, suggesting that the reduction in nuclear Keap1 may result in 
increased free nuclear nrf2 to induce transcription. Consistently, the 
suppression of Keap1 using shRNA (shKeap1) resulted in significant 
upregulation of IL-8 transcripts in response to acute shear stress. 
Interestingly; the over expression of Nrf2 using Nrf2-Ad-WT or 
Sulforaphane was also associated with significant upregulation of IL-8 
compared to controls. This study highlights the role of Keap1 in Nrf2 
activation under shear stress and indicates that activation of Nrf2 may 







































































Vascular endothelial cells stimulation is associated with the activation of different signalling pathways 
and transcription factors. Acute shear stress is known to induce different pro-inflammatory mediators 
such as IL-8. Nrf2 is activated by prolonged high shear stress promoting an antiinflammatory and 
athero-protective environment. However, little is known about the impact of acute shear stress on Nrf2 
and Keap1 function and its role in IL-8 regulation. We aimed to examine Nrf2-Keap1 complex 
activation in-vitro and its role in regulating IL-8 transcripts under acute arterial shear stress (12dyn/cm2) 
in venous endothelial cells (ECs). We note that  acute high shear stress caused a significant upregulation 
of Nrf2 target genes, HO-1 and GCLM and an increased IL-8 upregulation at 90 and 120 min. 
Mechanistically, acute high shear did not affect Nrf2 nuclear translocation but resulted in reduced 
nuclear Keap1, suggesting that the reduction in nuclear Keap1 may result in increased free nuclear nrf2 
to induce transcription. Consistently, the suppression of Keap1 using shRNA (shKeap1) resulted in 
significant upregulation of IL-8 transcripts in response to acute shear stress. Interestingly; the over 
expression of Nrf2 using Nrf2-Ad-WT or Sulforaphane was also associated with significant 
upregulation of IL-8 compared to controls. This study highlights the role of Keap1 in Nrf2 activation 
under shear stress and indicates that activation of Nrf2 may be deleterious in ECs in the context of acute 
haemodynamic injury.


































































Regulation of the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is 
achieved through physical interaction with its innate repressor, Kelch-like ECH-associating 
protein 1 (Keap1), which is required for both cytosolic sequestration and continuous targeted 
degradation of the transcription factor (1-3). Activation of the Keap1-Nrf2 complex is achieved 
via stress-sensing mechanisms, both intrinsically, within the complex itself, and extrinsically, 
through stress-responsive Mitogen activated protein kinase (MAPK) controlled 
phosphorylation (4, 5). Upon activation, Keap1 undergoes a conformational change and 
dissociates from Nrf2. This allows the transcription factor to bind to its reciprocal antioxidant 
response element (ARE) and regulate myriad stress-response target genes, including phase II 
detoxifying and antioxidant enzymes and glutathione producers such as heme-oxygenase 1 
(HO-1) and glutamylcysteine ligase modifier (GCLM) (1, 3). Prolonged high shear stress at 
athero-protected arterial sites is known to promote a quiescent, antiinflammatory and 
antioxidant status in endothelial cells (ECs) partly due to Nrf2 activation (5, 6). 
It is recognised that veins in the human body are exposed to low shear stress compared with 
arteries. The acute stimulation of venous ECs by sudden haemodynamic changes such as 
grafting of a long saphenous vein into the arterial circulation can be associated with the 
upregulation of different inflammatory mediators and signalling pathways such as MAPK and 
NF-kB (7, 8). However, little is known about Nrf2-Keap1 responses to an acute onset of shear 
stress in these venous ECs.
Interleukin-8 (IL-8) is a chemoattractant cytokine produced by ECs and activates neutrophils 
at inflammatory sites. IL-8 is regulated by MAPK, NF-kB and Nrf2 (9, 10) . Furthermore, it 
has been demonstrated that IL-8 can be activated by acute high shear stress or prolonged low 
shear (7, 11).

































































 In this study, we investigate the impact of acute shear stress in human umbilical vein ECs 
(HUVECs) on Nrf2-Keap1 complex and its potential role in mediating IL-8 transcription 
response.
2.   Materials and Methods
EC culture and shear stress
1mm thick Menzel glass microscope slides (Thermo Scientific, USA) were strerilised and air-
dried, a physical barrier area to cell growth was established by adhering modified, reusable 
flexiPERM cell culture chambers (Sarstedt, Germany) to the glass slide surface. The 
established growth area was coated with 700μl 1%(w/v) gelatin (Sigma Aldrich, USA) for 1 
hour at 37°C; the gelatin solution was then aspirated, prior to washing the slide with Dulbecco’s 
PBS and subsequent addition of 3mL pre-warmed Ready-to-use Endothelial Cell Growth 
Medium (ECGM: Promocell, Germany), containing final concentrations of 0.004 ml/ml 
endothelial cell growth supplement, 0.1 ng/ml recombinant human epidermal growth factor, 
1ng/ml recombinant human basic fibroblast growth factor, 90µg/ml heparin, 1µg/ml 
hydrocortisone, 100μg/ml penicillin, 100IU/ml streptomycin and 2mM L-Glutamine 
(Promocell and Gibco, USA). Human Umbilical Vein Endothelial Cells (HUVECs) (pooled 
from up to 4 donors) were purchased from Promocell (Germany). 2x105 cells/slide were 
cultured (≤Passage 4) for 48 hours to full confluency on glass slides (checked visually under 
microscope), with ECGM. HUVECs were then cultured overnight in Endothelial Cell Basal 
Medium (ECBM: Promocell) supplemented with 2% (v/v) FCS, 100μg/mL penicillin, 
100IU/mL streptomycin and 2mol/L L-Glutamine (with supplements removed). 
For shear stress exposure, HUVECs were exposed to laminar, unidirectional acute (4 hours) 
high shear stress  at 12 dyn/cm2 to simulate arterial rates of shear stress, for varying time points 
using parallel plate flow chambers  (Supplementary figure 1) or maintained in static conditions. 

































































Briefly, the glass slides were placed into the parallel plate chambers and sealed with a silicon 
sheet gasket. A reservoir containing 30mL M199 GlutaMax culture medium (Gibco, USA), 
supplemented with 2% (v/v) FCS, 100µg/ml penicillin and 100U/ml streptomycin, was 
attached to a closed-circuit loop of silicon tubing (VWR, USA and Elkay, UK) and connected 
to the chambers. HUVECs were then cultured at 37°C and 5% CO2 and shear stress was 
applied using a multi-channel peristaltic pump (Watson-Marlow, UK) in a dedicated incubator 
to maintain the temperature. Shear stress rates were calculated for a slit die assuming the 
viscosity of water at 37°C, using the following equation: τ=6µǪ/wh2. Where τ represents Shear 
Stress; µ, viscosity; Ǫ, flow rate; w, width and h, height.
Pharmacological over expression of Nrf2
Pharmacological activation and over expression of Nrf2 was performed prior to shear stress 
exposure using Sulforaphane (SFN), a naturally occurring isothiocyanate with Nrf2-inducing 
and antiinflammatory functions (5, 12). HUVECs were either pre-treated with SFN (Sigma 
Aldrich, USA) dissolved in DMSO or DMSO only for 4 hours.  A final concentration of 
5mol/mL was used as it was associated with maximum nuclear Nrf2 concentration 
(Supplementary figure 2A).
Adenoviral-mediated expression of WT and DN-Nrf2
Overexpression of wild-type Nrf2 (WT-Nrf2) and dominant-negative Nrf2 (DN-Nrf2) was 
achieved using recombinant adenoviruses (provided by Professor Paul Evans, University of 
Sheffield). The WT is known to result in over expression of Nrf2 while the DN results in the 
overexpression of a form of the protein  which lacks the N-terminal transcriptional activation 
domain, but the C-terminal DNA-binding and heterodimerisation domains are retained, thus, 
competes  with endogenous Nrf2 for binding to the ARE-motif without affecting the Keap1 
(13). The empty cassette (rAd66) was used as the negative control. Firstly, HUVECs were 

































































seeded in 6 well plates for assessment of overexpression or onto 1% gelatin-coated glass slides 
and cultured for 24 hours, as above, for shear stress exposure. The rAd66, DN-Nrf2 and WT-
Nrf2 containing adenoviruses were diluted in ECBM to achieve a final concentration of 1x107 
pfu/mL. Cells were cultured with adenoviruses for 18 hours and, after washing cells with 
DPBS, fresh ECBM added for a further 48 hours to enable maximal expression of viral 
proteins. Expression of DN-Nrf2 and WT-Nrf2 was assessed by Western blotting (WB) 
(Supplementary figure 2 B, C).  
Adenoviral-mediated knockdown of Keap1
Short hairpin RNAs against Keap1 (shKeap1) were cloned into pCpG-free MCS vectors 
(Invivogen) and the expression cassette was inserted into pDC511 (Microbix Biosystems, 
Canada) for adenoviral vector production, described previously (14). Knockdown of Keap1 
was performed similarly to above; briefly, HUVECs were cultured for 24 hours in ECGM, then 
incubated for a further 18 hours with 1x107pfu/mL Ad-shKeap1, or Ad-shLuciferase as a 
vehicle control, in ECBM. Following removal of the virus, cells were cultured for 24 hours and 
either analysed for Keap1 knockdown or exposed to shear stress.
Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR)
mRNA transcript levels were quantified by RT-qPCR with gene-specific primers for pro-
inflammatory genes: Interleukin-6 (IL-6), Interleukin-8 (IL-8); and ARE/Nrf2 target genes: 
Glutamate-cysteine ligase, modifier sub-unit (GCLM), and HO-1. Extraction and purification 
of total RNA was performed using miRNeasy Mini kit (Qiagen, Germany), as per 
manufacturer’s instructions. Reverse transcription of total RNA was performed using 
transcriptor first strand cDNA synthesis kit (Roche, Switzerland). All RT-qPCR reactions were 
performed in triplicate. Expression of the specific target genes relative to the house-keeping 
gene, β-Tubulin, were calculated using the delta-delta CT method (15).


































































Total HUVEC protein was extracted with 1% (w/v) SDS lysis buffer, or, alternatively, cell 
compartment lysates were prepared with the NE-PER Nuclear and Cytoplasmic extraction kit 
(ThermoFisher).  All Polyacrylamide Gel Electrophoresis (PAGE) were performed using the 
Bio-Rad Mini format 1-D electrophoresis system and 4-15% Mini-PROTEAN TGX stain free 
gels (Bio-Rad, USA). Gels were photoactivated using the ChemiDoc XRS+ imaging system 
(Bio-Rad) for endpoint normalisation of Western blot data to total protein concentration per 
lane. Following transfer, 0.2µM Nitrocellulose membranes (Bio-Rad), were blocked in 5% 
(w/v) semi-skimmed milk powder and primary antibodies were incubated overnight at 4°C 
(See supplementary methods for details). Primary antibodies were detected by Horseradish 
Peroxidase-conjugated secondary antibodies for 1 hour at room temperature  and Luminata 
Forte Western HRP substrate reagent (Millipore, USA). Membranes were imaged using the 
ChemiDoc XRS+ imaging system and detected protein bands were quantified by densitometry 
and normalised to the stain-free loading control.
Primary antibodies used were as follows: Nrf2,  rabbit anti-Nrf2(c20) (0.2g/mL; Santa Cruz 
Biotechnology, sc-722); Keap1, goat anti-Keap1 (0.4g/mL; Santa Cruz Biotechnology, sc-
15246); Lamin A/C, rabbit anti-Lamin A/C (0.33g/mL; Santa Cruz Biotechnology, sc-6215) 
for 1 hour at RT; Glyceraldehye 3-Phosphate dehydrogenase (GAPDH), mouse anti-GAPDH 
(3.33g/mL; Millipore, MAB374).
Statistical analysis
For experiments where only two groups were analysed, data were subjected to a paired, two- 
tailed t-test. For experiments where more than two groups were analysed, a one- or two-way 
ANOVA was used depending on the number of independent variables, followed by post-hoc 
pairwise comparisons with Bonferroni correction for multiple comparisons. The cut-off value 

































































for statistical significance was 0.05. Data are presented as mean±SEM of 4-6 independent 
experiments. All statistical analysis was performed with GraphPad Prism 7.0.
Results
1- Nrf2 and Keap 1 activation under acute shear stress
HUVECs exposure to acute shear stress at 12dyn/cm2 for 30 minutes did not result in changes 
in nuclear Nrf2 suggesting that acute shear stress is not associated with Nrf2 activation (nuclear 
translocation) at that time point (figure 1). Interestingly, we noted significant reduction in 
nuclear Keap1 with a concomitant increase in cytosolic Keap 1 suggesting that acute shear 
stress can result in Keap1 export from the nucleus (figure 1). These changes were associated 
with increased expression of Nrf2 regulated genes (HO-1 and GCLM) (figure 2 A, B) and an 
increase in IL-8 transcript levels after 90 and 120 minutes of exposure to acute shear stress 
compared to static controls (figure 2 C). These findings indicate that although acute shear stress 
did not increase Nrf2 nuclear translocation however, the reduction in nuclear Keap1 may have 
resulted in the presence of more unbound (active) Nrf2 in the nucleus to activate HO-1 and 
GCLM transcription, which occurs at the same time as the upregulation of pro-inflammatory 
IL-8. 
The findings above raised the possibility that Keap1 reduction and associated increased levels 
of free Nrf2 can tip the fine balance of the tightly controlled Nrf2-Keap1 system, leading to 
increased levels of unbound Nrf2, which may contribute to an EC inflammatory response under 
acute shear stress conditions.
To test the above hypothesis, we reasoned that the reduction of Keap1 may increase 
inflammatory responses to acute shear stress.  Using a targeted shRNA (shKeap1), Keap 1 was 
knocked down by 25% as demonstrated by reduced Keap-1 transcripts and increased HO-1 
transcripts (figure 2 D, E) The knock down of Keap1 resulted in increase in IL-8 transcripts at 

































































static and under 90 and 120 minutes of exposure to acute shear stress compared to shLuc (figure 
2 F). 
2- Hyperactivation of Nrf2 and acute shear stress leads to induction of a pro-
inflammatory gene response
To further examine the role of Keap1-Nrf2 imbalance under acute shear stress, we investigated 
the role of over-activation of Nrf2 on responses to acute shear stress.
Nrf2 over-activation was performed pharmacologically, using SFN, a naturally occurring 
isothiocyanate with Nrf2-inducing and antiinflammatory functions (5, 12) or via an adenoviral-
mediated overexpression of WT-Nrf2. SFN treatment of HUVECs increased mRNA levels of 
HO-1 under static conditions and after exposure to acute shear stress at 90 and 120 minutes 
compared to DMSO control (Figure 3A). We noted significant increase in IL-8 transcripts in 
SFN-treated samples in static and acute shear stress-exposed HUVECs compared to DMSO 
control (figure 3B).
To confirm the above results, we transfected HUVECs with WT- Nrf2 1x107pfu/mL which 
resulted in a significant increase in Nrf2 protein levels was associated with an increase in HO-1 
transcripts at static and under acute shear stress compared to control (figure 3C). Again we 
noted a concomitant upregulation of IL-8 at static and under acute shear stress (figure 3D).
To determine if the IL-8 increase is Nrf2 dependent, we inhibited Nrf2 using an adenoviral-
mediated overexpression of a dominant-negative form of the protein (DN-Nrf2) which lacks 
the N-terminal transcriptional activation domain, but the C-terminal DNA-binding and 
heterodimerisation domains are retained, thus, competes  with endogenous Nrf2 for binding to 
the ARE-motif (13).  Following treatment with DN-Nrf2, HUVECs were exposed to shear 
stress for 90 and 120 minutes. Acute shear stress did not result in HO-1 activation compared 
to control under static or acute shear stress conditions as expected (figure 3E), but, more 

































































importantly, we observed no suppression in IL-8 response to acute shear stress compared to 
rAd66 at the same time points of exposure to shear (figure 3F). 
Discussion
Inflammation and oxidative stress are inextricably linked to vascular injury associated with 
damage to the vascular wall or harmful haemodynamic stimulation (5, 7, 8). Such pathogenic 
shifts in the endothelium, from quiescence to dysfunction, results in a change in gene 
expression profiles from antiinflammatory and antioxidant, to proinflammatory and oxidative 
(7, 8, 16-18). Here, we investigated the response of the Nrf2-Keap1 complex to acute shear 
stress stimulation in venous ECs to simulate exposure of venous ECs to arterial shear stress 
levels during venous grafting and examined the role that Nrf2 activation has on ARE and IL-8 
pro-inflammatory gene expression. 
We noted that HO-1 and GCLM transcript levels were increased under acute shear stress 
indicative of the ARE-gene response activation. However, similarly to what we previously 
reported, acute shear stress was not associated with increased nuclear translocation of Nrf2 in 
venous ECs (8). When we looked at Keap1 expression and translocation, we noted a reduction 
in nuclear Keap1, suggesting that Keap1 reduction in the nucleus may allow for more ARE 
activation due to the presence of more unbound Nrf2 in the nucleus. 
It has been previously observed that shear stress exposure improves Nrf2 stability via lipid 
peroxidation by NADPH oxidase (NOX) action, which can oxidatively modify Keap1 to 
induce its dissociation from Nrf2 (19). Additionally, covalent modification of Nrf2, by PKC-
induced phosphorylation at Serine residue 40, is recognised to further stabilise Nrf2 and further 
supress its association with Keap1, which may possibly explain the increased ARE mRNA 
response (6, 20, 21), but cannot explain the reduction in Keap1 under acute shear conditions.

































































As previously reported, acute shear stress was associated with the activation of pro-
inflammatory IL-8 transcripts (7); however, surprisingly we noted that inhibiting Keap1 
increased IL-8 upregulation in response to acute shear stress compared to controls, despite 
increased activation of the protective ARE gene response basally. Moreover, the over 
expression of Nrf2 was also associated with increased pro inflammatory response to acute shear 
stress demonstrated by increased transcript levels of IL-8. Furthermore, the presence of DN-
Nrf2, which is not known to influence Keap1, did not suppress IL-8, despite suppressing HO-
1 activation.
It has been demonstrated previously that the exposure of arterial ECs in-vitro and in-vivo to 
prolonged high shear stress is associated with increased nuclear Nrf2 and the presence of 
antiinflammatory antiatherosclerotic environment (5, 22). However, it seems that in-vitro 
hyperactivation of Nrf2 can impair EC adhesion and repair (23). Moreover, global deletion of 
Nrf2 (Nrf2‐/‐) in hypercholesterolemic mice was associated with reduced atherosclerosis, 
despite the predicted reduction in antioxidant defence and inflammation (24, 25). While this 
has been explained previously by effects on lipid metabolism (24), our results suggests that 
Nrf2-Keap1 pathway is more complicated and Keap1 may play a more important role in 
regulating the positive or negative effects of Nrf2 in different contexts.
Recent evidence from cancer studies are beginning to reveal the possible negative impacts that 
the activation of Nrf2 can have in pathological conditions. This evidence points towards the 
unconstrained activity of Nrf2 in cancer as deleterious and emphasises the importance of 
context and dose dependency with Nrf2 activation (26-28). Furthermore, Taguchi et al, 
examined the effects of graded reduction of Keap1 expression in adult mice. When challenged 
with APAP, Keap1flox/− mice were more protected from mortality than wild-type and 
even Keap1flox/−::Albumin-Cre mice. In contrast, a decrease in Keap1 levels to less than 50% 

































































resulted in increased mortality in a study of 2-year-old mice indicating that the sustained 
systemic activation of Nrf2 is disadvantageous (29).
 
Our current study highlights two new findings. Firstly, we demonstrated for the first time that 
acute high shear stress can lead to increased Keap1 export from the nucleus. Secondly that a 
nuclear reduction in Keap1 can lead to more free nuclear Nrf2, resulting in ARE gene 
activation, but, more importantly, seems to contribute to the pro-inflammatory response 
following acute high shear stress by regulating IL-8 transcripts.
Our study has a few limitations. It is an in-vitro study that aimed mainly to look at the activity 
of Nrf2 under acute shear stress. The use of shKeap1 only resulted in 25% reduction of Keap1, 
however, this seems to be enough to increase ARE regulated gene HO-1. Furthermore, it is 
important to point that this experimental model used culture media not blood as the circulating 
fluids and the temperature was maintained during the experiment under rigid control which is 
different to the circulating fluids in the human body and the fluctuation of temperature that can 
affect viscosity (30). Moreover, this current model does not take into account any potential 
turbulent flow patterns generated at the anastomosis site in non-interposition grafts models (31, 
32). It will be interesting in the future to investigate in depth the impact of Keap1 
overexpression on inflammatory responses and to validate these findings in-vivo or ex-vivo 
where such limitation can be minimised.
Conclusion
The findings presented here, regarding the paradoxical, pro-inflammatory function of Nrf2 
under acute shear stress, represent a contrasting view from the widely accepted notion that Nrf2 
possesses antiinflammatory potential, highlighting the importance of context and levels with 
this transcription factor.  These observations indicate the necessity for tight regulation of the 

































































Nrf2‐dependent transcriptional programme and raise a cautionary note on modulation of Nrf2 
as an adjunctive therapy to reduce inflammation.
Disclosure: none of the authors have conflict of interest to declare.
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Figure legends
Figure 1. Nrf2 and Keap 1 activation under acute shear stress
Representative image of WB of cytosolic and nuclear Nrf2 and Keap1 from HUVECs exposed 
to acute shear stress for 30 mins or kept under static conditions, all WBs were normalised using 
bands detected on stain free gel and expressed as a fold change in protein level relative to static. 
Approximate molecular weights in kDa are indicated adjacent to representative blots (n=6). 
Figure 2. ARE genes and IL-8 activation under acute shear stress
(A) Relative mRNA levels of HO-1, (B) GCLM and (C) IL-8 from HUVECs exposed to acute 
shear stress for 90 and 120 minutes or maintained in static conditions (n=4). (D) Relative 
mRNA levels of Keap1 and (E) HO-1 in HUVECs infected with adenoviruses containing 
shRNAs against Keap1 (shKeap1), or adenoviral vector control containing shRNAs against 
Renilla Luciferase (shLuc), at 1x107pfu/mL (n=4). (F) Relative mRNA levels of IL-8 in and 
subsequently exposed to acute shear stress for 90 and 120 minutes or maintained in static 
conditions (n=4). mRNA levels were normalised to -tubulin and expressed as a fold-change 
relative to static control. 

































































Figure 3. Hyperactivation of Nrf2 and acute shear stress leads to induction of a 
proinflammatory gene response
Relative mRNA levels of HO-1(3A)  and IL-8 9 (3B) in HUVECs pre-treated with 5mol/L 
SFN, or vehicle, DMSO (0.05% (v/v)), and subsequently exposed to acute shear stress for 90 
and 120 minutes or maintained in static conditions.  Relative mRNA levels of HO-1(3C) and 
IL-8 (3D) from HUVECs infected with WT-Nrf2 containing- or rAd66 empty vector 
adenovirus at 1x107 pfu/mL and subsequently exposed to acute shear stress for 90 and 120 
minutes or maintained in static conditions. Relative mRNA levels of HO-1(3E) and IL-8 (3F) 
from HUVECs infected with DN-Nrf2 containing- or rAd66 control-adenoviruses, at 1x107 
pfu/mL, and subsequently exposed to acute shear stress for 90 and 120 minutes or maintained 
in static conditions. mRNA expression data were normalised to -tubulin and expressed as a 
fold-change relative to rAd66 static control (n=4). 

































































Figure 1. Nrf2 and Keap 1 activation under acute shear stress 
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Figure 2. ARE genes and IL-8 activation under acute shear stress 
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Figure 3. Hyperactivation of Nrf2 and acute shear stress leads to induction of a proinflammatory gene 
response 
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Supplementary figure 1. Schematic representation of the experimental shear stress inducing system 
in-vitro.
































































Supplementary figure 2.  Representative image of WB of  Nrf2 from HUVECs (A) Activation of 
Nrf2 with different doses of SFN. (B) Expression of mutant type of Nrf2 using Nrf2-Ad-DN. (C) 
Over expression of Nrf2 using Nrf2-Ad-WT.
Page 22 of 21
http://mc.manuscriptcentral.com/perfusion
Perfusion
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
